Alcohol ingestion by donors amplifies experimental airway disease after heterotopic transplantation

American Journal of Respiratory and Critical Care Medicine

Volumn 176, Issue 11, 2007, Pages 1161-1168

  Mitchell, Patrick O ^a,b   Guidot, David M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Fibrosis; Lung transplant; Obliterative bronchiolitis; Transforming growth factor 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; TRANSFORMING GROWTH FACTOR BETA1;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALLOGRAFT; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; BRONCHIOLITIS OBLITERANS; CONTROLLED STUDY; DISEASE SEVERITY; FIBROSIS; HETEROTOPIC TRANSPLANTATION; INFLAMMATION; LUNG TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECIPIENT; RESPIRATORY TRACT DISEASE; TRACHEA;

ACTINS; ALCOHOL DRINKING; ANIMALS; BRONCHIOLITIS OBLITERANS; COLLAGEN; DISEASE SUSCEPTIBILITY; HISTOCOMPATIBILITY; LYMPHOCYTES; MALE; MUSCLE, SMOOTH; ORGAN TRANSPLANTATION; POSTOPERATIVE PERIOD; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX; TISSUE DONORS; TISSUE SURVIVAL; TRACHEA; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION, HETEROTOPIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 36849038942     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200702-255OC     Document Type: Article

References (43)

1. Boehler A, Kesten S, Weder W, Speich R. Bronchiolitis obliterans after lung transplantation: a review. Chest 1998;114:1411-1426.
2. Boehler A, Estenne M. Post-transplant bronchiolitis obliterans. Eur Respir J 2003;22:1007-1018.
3. Sharples LD, McNeil K, Stewart S, Wallwork J. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant 2002;21:271-281.
4. Scholma J, Slebos DJ, Boezen HM, van den Berg JW, van der Bij W, de Boer WJ, Koeter GH, Timens W, Kauffman HF, Postma DS. Eosinophilic granulocytes and interleukin-6 level in bronchoalveolar lavage fluid are associated with the development of obliterative bronchiolitis after lung transplantation. Am J Respir Crit Care Med 2000;162:2221-2225.
5. DiGiovine B, Lynch JP III, Martinez FJ, Flint A, Whyte RI, Iannettoni MD, Arenberg DA, Burdick MD, Glass MC, Wilke CA, et al. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8. J Immunol 1996;157:4194-4202.
6. Riise GC, Andersson BA, Kjellstrom C, Martensson G, Nilsson FN, Ryd W, Schersten H. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant. Eur Respir J 1999;14:1123-1130.
7. Hauber HP, Mikkila A, Erich JM, Kroger N, Meyer A, Schoder V, Zander AR, Pforte A. TNFa, interleukin-10 and interleukin-18 expression in cells of the bronchoalveolar lavage in patients with pulmonary complications following bone marrow or peripheral stem cell transplantation: a preliminary study. Bone Marrow Transplant 2002;30:485-490.
8. Reynaud-Gaubert M, Marin V, Thirion X, Farnarier C, Thomas P, Badier M, Bongrand P, Giudicelli R, Fuentes P. Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration. J Heart Lung Transplant 2002;21:721-730.
9. Ward C, Whitford H, Snell G, Bao H, Zheng L, Reid D, Williams TJ, Walters EH. Bronchoalveolar lavage macrophage and lymphocyte phenotypes in lung transplant recipients. J Heart Lung Transplant 2001;20:1064-1074.
10. Silkoff PE, Caramori M, Tremblay L, McClean P, Chaparro C, Kesten S, Hutcheon M, Slutsky AS, Zamel N, Keshavjee S. Exhaled nitric oxide in human lung transplantation: a noninvasive marker of acute rejection. Am J Respir Crit Care Med 1998;157:1822-1828.
11. Bando K, Paradis IL, Similo S, Konishi H, Komatsu K, Zullo TG, Yousem SA, Close JM, Zeevi A, Duquesnoy RJ, et al. Obliterative bronchiolitis after lung and heart-lung transplantation: an analysis of risk factors and management. J Thorac Cardiovasc Surg 1995;110:4-13. [Discussion, 13-14.]
12. Sharples LD, Tamm M, McNeil K, Higenbottam TW, Stewart S, Wallwork J. Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation - early risk factors. Transplantation 1996;61:560-566.
13. Khalifah AP, Hachem RR, Chakinala MM, Yusen RD, Aloush A, Patterson GA, Mohanakumar T, Trulock EP, Walter MJ. Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome. Am J Transplant 2005;5:2022-2030.
14. Jackson CH, Sharples LD, McNeil K, Stewart S, Wallwork J. Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities? J Heart Lung Transplant 2002;21:658-666.
15. King MB, Pedtke AC, Levrey-Hadden HL, Hertz MI. Obliterative airway disease progresses in heterotopic airway allografts without persistent alloimmune stimulus. Transplantation 2002;74:557-562.
16. Ramirez AM, Takagawa S, Sekosan M, Jaffe HA, Varga J, Roman J. Smad3 deficiency ameliorates experimental obliterative bronchiolitis in a heterotopic tracheal transplantation model. Am J Pathol 2004;165:1223-1232.
17. Levine SM, Bryan CL. Bronchiolitis obliterans in lung transplant recipients: the "thorn in the side" of lung transplantation. Chest 1995;107:894-897.
18. Holguin F, Moss I, Brown LA, Guidot DM. Chronic ethanol ingestion impairs alveolar type II cell glutathione homeostasis and function and predisposes to endotoxin-mediated acute edematous lung injury in rats. J Clin Invest 1998;101:761-768.
19. Lois M, Brown LA, Moss IM, Roman J, Guidot DM. Ethanol ingestion increases activation of matrix metalloproteinases in rat lungs during acute endotoxemia. Am J Respir Crit Care Med 1999;160:1354-1360.
20. Velasquez A, Bechara RI, Lewis JF, Malloy J, McCaig L, Brown LA, Guidot DM. Glutathione replacement preserves the functional surfactant phospholipid pool size and decreases sepsis-mediated lung dysfunction in ethanol-fed rats. Alcohol Clin Exp Res 2002;26:1245-1251.
21. Bechara RI, Brown LA, Roman J, Joshi PC, Guidot DM. Transforming growth factor β1 expression and activation is increased in the alcoholic rat lung. Am J Respir Crit Care Med 2004;170:188-194.
22. Bechara RI, Pelaez A, Palacio A, Joshi PC, Hart CM, Brown LA, Raynor R, Guidot DM. Angiotensin II mediates glutathione depletion, transforming growth factor-β1 expression, and epithelial barrier dysfunction in the alcoholic rat lung. Am J Physiol Lung Cell Mol Physiol 2005;289:L363-L370.
23. Moss M, Bucher B, Moore FA, Moore EE, Parsons PE. The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults. JAMA 1996;275:50-54.
24. Moss M, Parsons PE, Steinberg KP, Hudson LD, Guidot DM, Burnham EL, Eaton S, Cotsonis GA. Chronic alcohol abuse is associated with an increased incidence of acute respiratory distress syndrome and severity of multiple organ dysfunction in patients with septic shock. Crit Care Med 2003;31:869-877.
25. Moss M, Guidot DM, Wong-Lambertina M, Ten Hoor T, Perez RL, Brown LA. The effects of chronic alcohol abuse on pulmonary glutathione homeostasis. Am J Respir Crit Care Med 2000;161:414-419.
26. Freimark D, Aleksic I, Trento A, Takkenberg JJ, Valenza M, Admon D, Blanche C, Queral CA, Azen CG, Czer LS. Hearts from donors with chronic alcohol use: a possible risk factor for death after heart transplantation. J Heart Lung Transplant 1996;15:150-159.
27. Houyel L, Petit J, Nottin R, Duffet JP, Mace L, Neveux JY. Adult heart transplantation: adverse role of chronic alcoholism in donors on early graft function. J Heart Lung Transplant 1992;11:1184-1187.
28. Mitchell PO, Guidot DM. Chronic alcohol ingestion by donors amplifies obliterative bronchiolitis in a rodent model of lung transplantation [abstract]. J Heart Lung Transplant 2007;26(2 Suppl 1):S197.
29. Mitchell PO, Guidot DM. Chronic ethanol ingestion by donors predisposes the lung to injury in a rat model of lung transplantation [abstract]. Alcohol Clin Exp Res 2006;30(6 Suppl 1):224A.
30. Woessner JF Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961;93:440-447.
31. Mitchell PO, Pavlath GK. Skeletal muscle atrophy leads to loss and dysfunction of muscle precursor cells. Am J Physiol Cell Physiol 2004;287:C1753-C1762.
32. Schacker TW, Nguyen PL, Beilman GJ, Wolinsky S, Larson M, Reilly C, Haase AT. Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis. J Clin Invest 2002;110:1133-1139.
33. Adams BF, Brazelton T, Berry GJ, Morris RE. The role of respiratory epithelium in a rat model of obliterative airway disease. Transplantation 2000;69:661-664.
34. Ramirez AM, Shen Z, Ritzenthaler JD, Roman J. Myofibroblast transdifferentiation in obliterative bronchiolitis: TGF-β signaling through Smad3-dependent and -independent pathways. Am J Transplant 2006;6:2080-2088.
35. Zhou H, Latham CW, Zander DS, Margolin SB, Visner GA. Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts. J Heart Lung Transplant 2005;24:1577-1585.
36. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003;200:500-503.
37. Fernandez FG, Jaramillo A, Chen C, Liu DZ, Tung T, Patterson GA, Mohanakumar T. Airway epithelium is the primary target of allograft rejection in murine obliterative airway disease. Am J Transplant 2004;4:319-325.
38. El-Gamel A, Sim E, Hasleton P, Hutchinson J, Yonan N, Egan J, Campbell C, Rahman A, Sheldon S, Deiraniya A, et al. Transforming growth factor β (TGF-β) and obliterative bronchiolitis following pulmonary transplantation. J Heart Lung Transplant 1999;18:828-837.
39. Charpin JM, Valcke J, Kettaneh L, Epardeau B, Stern M, Israel-Biet D. Peaks of transforming growth factor-β mRNA in alveolar cells of lung transplant recipients as an early marker of chronic rejection. Transplantation 1998;65:752-755.
40. Hu B, Wu Z, Phan SH. Smad3 mediates transforming growth factor-β-induced α-smooth muscle actin expression. Am J Respir Cell Mol Biol 2003;29:397-404.
41. Neuringer IP, Mannon RB, Coffman TM, Parsons M, Burns K, Yankaskas JR, Aris RM. Immune cells in a mouse airway model of obliterative bronchiolitis. Am J Respir Cell Mol Biol 1998;19:379-386.
42. Happel KI, Nelson S. Alcohol, immunosuppression, and the lung. Proc Am Thorac Soc 2005;2:428-432.
43. Joshi PC, Applewhite L, Ritzenthaler JD, Roman J, Fernandez AL, Eaton DC, Brown LA, Guidot DM. Chronic ethanol ingestion in rats decreases granulocyte-macrophage colony-stimulating factor receptor expression and downstream signaling in the alveolar macrophage. J Immunol 2005;175:6837-6845.